Literature DB >> 22959234

Skin involvement in cutaneous and systemic vasculitis.

Angelo V Marzano1, Pamela Vezzoli, Emilio Berti.   

Abstract

Cutaneous vasculitides are a heterogeneous group of inflammatory disorders affecting skin blood vessels. They may be triggered by several factors, such as infection or drug, or may be related to underlying disease, notably connective tissue or malignancies. However, vasculitis occurs without any demonstrable triggering agents in a relevant number of patients. On the other hand, vasculitic skin lesions may manifest as a component of vasculitis affecting also internal organs; in someone of these patients, skin involvement occurs initially as the sole sign of disease, leading to consider cutaneous vasculitis a diagnosis of exclusion. In this review, we have focused on the most common variants of cutaneous vasculitis, including cutaneous small vessel vasculitis and urticarial vasculitis as well as Henoch-Schönlein purpura, a systemic form in which however skin involvement often predominates. We have also argued on livedoid vasculopathy, a cutaneous entity which, although nonfrankly vasculitic in origin, is frequently associated with connective tissue disease. Finally, we have analyzed the variety of cutaneous manifestations that may develop during the course of the main systemic vasculitides, such as Wegener's granulomatosis, Churg-Strauss syndrome and polyarteritis nodosa.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959234     DOI: 10.1016/j.autrev.2012.08.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  13 in total

1.  [Cutaneous polyarteritis nodosa: A rare cause of chronic ulcers].

Authors:  T M Jansen; N-Ph Hoff
Journal:  Hautarzt       Date:  2015-10       Impact factor: 0.751

Review 2.  Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review.

Authors:  Giovanni Genovese; Simona Tavecchio; Emilio Berti; Franco Rongioletti; Angelo Valerio Marzano
Journal:  Rheumatol Int       Date:  2018-05-02       Impact factor: 2.631

3.  Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis.

Authors:  Dae Suk Kim; Dongyun Shin; Tae-Gyun Kim; Sung Hee Kim; Do Young Kim; Soo Min Kim; Min-Geol Lee
Journal:  Rheumatol Int       Date:  2014-10-05       Impact factor: 2.631

Review 4.  Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.

Authors:  Angelo Valerio Marzano; Maria Gabriella Raimondo; Emilio Berti; Pier Luigi Meroni; Francesca Ingegnoli
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

5.  Purpura, petechiae, and bullae as first signs of juvenile granulomatosis with polyangiitis.

Authors:  Saara Rawn; Paivi Miettunen; Holly A Brown; Heinrike Schmeling
Journal:  Eur J Pediatr       Date:  2014-03-28       Impact factor: 3.860

Review 6.  Cutaneous manifestations of acute kidney injury.

Authors:  Gavin A Esson; Amaani B Hussain; Simon J Meggitt; Nick J Reynolds; John A Sayer
Journal:  Clin Kidney J       Date:  2021-12-09

7.  Urticarial vasculitis induced by OTC diet pills: a case report.

Authors:  Iván Chérrez Ojeda; Enrique Loayza; Leonardo Greiding; Juan Carlos Calderón; Annia Cherrez; Farid Adum
Journal:  World Allergy Organ J       Date:  2015-04-16       Impact factor: 4.084

8.  Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy.

Authors:  Wenji Chen; Lina Fan; Yanyan Wang; Xiaohu Deng
Journal:  J Pain Res       Date:  2017-03-17       Impact factor: 3.133

9.  Henoch-Schonlein purpura presenting sequentially as nodular rash, erythema nodosum, and palpable purpura.

Authors:  Kandan Balamurugesan; Stalin Viswanathan
Journal:  J Family Community Med       Date:  2014-01

10.  Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.

Authors:  Kai-Jun Zhu; Pei-Dan Yang; Qiang Xu
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.